{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-238627","form_type":"8-K","ticker":"STOK","cik":"0001623526","company_name":"Stoke Therapeutics, Inc.","filed_at":"2023-09-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.596731+00:00","generated_at":"2026-06-10T12:04:52.453735+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Stoke Therapeutics appoints Ian Smith to Board of Directors","bullets":["Ian Smith appointed as Class II director effective September 19, 2023.","He will receive an annual cash retainer of $40,000 and an initial stock option for 96,340 shares (~$305k fair value).","Smith brings over 20 years experience; served as EVP/COO/CFO at Vertex Pharmaceuticals.","He currently serves on boards of Solid Biosciences (SLDB), Foghorn Therapeutics (FHTX), and others."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-238627","json":"https://secwatch.observer/filing/0001193125-23-238627.json","markdown":"https://secwatch.observer/filing/0001193125-23-238627.md","text":"https://secwatch.observer/filing/0001193125-23-238627.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1623526/000119312523238627/0001193125-23-238627-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1623526/000119312523238627/d516489d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T12:04:52.453735+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"24be3ed012","claim":"Ian F. Smith was elected as Class II director at Stoke Therapeutics, Inc..","evidence_excerpt":"elected Ian F. Smith, to serve on the Board as a Class II director, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1623526/000119312523238627/0001193125-23-238627-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Class II director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}